Drug Profile
AVE 5376
Alternative Names: AVE5376Latest Information Update: 30 Mar 2007
Price :
$50
*
At a glance
- Originator sanofi-aventis
- Class Antihyperglycaemics
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 13 Feb 2007 Discontinued - Phase-I for Type-2 diabetes mellitus in France (unspecified route)
- 24 Feb 2006 Phase-I clinical trials in Type-2 diabetes mellitus in France (unspecified route)